Biotech and pharmaceutical stocks underperformed the broader markets Monday, with the Nasdaq and Amex biotechnology indices down by 3.2.% and 3.3%, respectively. Among individual stocks, notable movers were: Seattle Genetics ( SGEN), up 6.4% at $8.62 Omrix Biopharmaceuticals ( OMRI), up 5% at $15.48 Vertex ( VRTX), up 4.9% at $22 Bristol-Myers Squibb ( BMY), up 3.9% at $18.33. Amylin ( AMLN), down 14% at $8.44 Alnylam ( ALNY), down 10.8% at $18.88 Nektar ( NKTR), down 8.4% at $4.15 Alkermes ( ALKS), down 8.3% at $9.11
